LRMR – larimar therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "outperform" rating re-affirmed by analysts at William Blair.
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024 [Yahoo! Finance]
Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024
Is Larimar Therapeutics (LRMR) the Best Multibagger Stock to Buy Heading into 2025? [Yahoo! Finance]
Form 8-K Larimar Therapeutics, For: Nov 18
Form SC 13G/A Larimar Therapeutics, Filed by: Blue Owl Capital Holdings LP
Form SC 13G/A Larimar Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
Form SC 13G/A Larimar Therapeutics, Filed by: Verition Fund Management LLC
Form SC 13G Larimar Therapeutics, Filed by: GOLDMAN SACHS GROUP INC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.